Clinical Study Data Request Registered Users, Please Login

Scroll down the list of studies provided below. Studies are listed by study medicine in alphabetical order. Alternatively you can browse the list of studies using the search function.

To select studies and submit a research proposal or enquiry, go back to the Home page and select View and submit.

This takes you back to the previous page to enable you to view studies from a different sponsor.

Select medicine, medical condition or phase from the drop down boxes. This searches all the available clinical studies. Selecting from more than one drop down box will “and” the criteria.

Find by:

Alternatively search for studies using the Sponsor's Clinical Study Identification Number or study title by entering text and clicking search.


3581 found

Click the study title to find more information about the study.

Study of Once-Daily Abacavir/Lamivudine versus Tenofovir/Emtricitabine, Administered with Efavirenz in Antiretroviral-Naive, HIV-1 Infected Adult Subjects

Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus I, Phase: 4, Clinical Study ID: CNA109586, Sponsor: ViiV
A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of SYR-322 in Subjects With Type 2 Diabetes in Japan

Medicine: alogliptin, Condition: Diabetes Mellitus, Type 2, Phase: 2, Clinical Study ID: SYR-322/CCT-001, Sponsor: Takeda
A Randomized, Double-Blind Study of Tomoxetine Hydrochloride, Methylphenidate Hydrochloride, and Placebo in Pediatric Outpatients with Attention Deficit/Hyperactivity Disorder

Medicine: Atomoxetine, Condition: Attention Deficit Hyperactivity Disorder, Phase: 2, Clinical Study ID: B4Z-MC-HFBD, Sponsor: Lilly
DS-DU-176b PRT007
Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

Medicine: Edoxaban, Condition: Arthroplasty, Replacement, Hip;   Thrombosis, Phase: 2, Clinical Study ID: DU-176b PRT007, Sponsor: Daiichi Sankyo
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Medicine: Brivaracetam, Condition: Epilepsy, Phase: 3, Clinical Study ID: NO1252, Sponsor: UCB
A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients With High Risk Hypertension

Medicine: amlodipine/benazepril hcl, Condition: Hypertension, Phase: 3, Clinical Study ID: CCIB002I2301, Sponsor: Novartis
Multi-center, single-arm study to assess the safety, efficacy, discontinuation rate and pharmacokinetics of the low-dose levonorgestrel intrauterine contraceptive system (LCS12) in post-menarcheal female adolescents under 18 years of age for 1 year, and an optional 2-year extension phase

Medicine: Levonorgestrel, Condition: Contraception, Phase: 3, Clinical Study ID: 14371, Sponsor: Bayer
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Medicine: BI 54903, Condition: Asthma, Phase: 2, Clinical Study ID: 1248.7, Sponsor: Boehringer Ingelheim
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of CDP870 in Patients With Early-stage Rheumatoid Arthritis Who Are Naïve to Methotrexate and Have Poor Prognostic Factors

Medicine: certolizumab pegol, Condition: Rheumatoid Arthritis, Phase: 3, Clinical Study ID: CDP870-275-11-001, Sponsor: Astellas
An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, a
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Next Last